Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04892017
Title A Phase 1/2 Study of DCC-3116 in Patients With RAS/MAPK Pathway Mutant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Deciphera Pharmaceuticals LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Rutgers Cancer Institute RECRUITING New Brunswick New Jersey 08901 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
Oregon Health and Science University RECRUITING Portland Oregon 97239 United States Details
Hospital of the University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
NEXT Oncology RECRUITING Austin Texas 78758 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
University of Wisconsin Clinical Science Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field